Muscle wasting is a serious issue as we age or fall ill. Sarcopenia hits elderly folks, making their muscles shrink faster. Cachexia is worse, often tied to illnesses like cancer. Both have different roots, but they share some molecular tactics. Figuring out these differences and similarities is cru
Imagine you're trying to live healthier, and you download an app to help. But does adding game-like features make these health apps more effective? That's the question researchers wanted to answer. They looked at studies that compared apps with and without gamification. The goal was to see if these
Imagine you have a tumor, a dangerous cell cluster waging war within your body. Now, imagine scientists using a special kind of scan called Positron Emission Tomography (PET) to watch how your immune system responds to this invader. This isn’t just about the tumor anymore; it's about understanding h
Imagine you've just had bariatric surgery to help combat obesity and related health issues. You might be thinking, "Great! All my problems are solved. " But hold on a minute. This surgery isn't a magic solution that works the same way for everyone, especially if you have type 2 diabetes. What happen
In Eastern India, a significant number of people live with disabilities, and they often face health challenges that are not well met. This is partly because healthcare professionals might lack the right knowledge and understanding about disabilities. A recent study took a closer look at this issue i
Have you ever wondered how a tax on sugary drinks could influence kids' choices? Well, down in South Africa, researchers took a close look at this very topic. Over four years, they observed how a tax on sweet beverages, known as the health promotion levy, was changing kids' drinking habits. They did
Imagine you're battling advanced biliary tract cancer (ABTC), and your doctors suggest a mix of drugs: nivolumab, modified gemcitabine, and S-1. This combo showed promise in a past trial, but PD-L1 levels didn't tell us much about how well it would work. So, scientists looked at another marker, LAG-
You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has
Immune treatments, or immune checkpoint inhibitors (ICIs), are game-changers for some people with far-advanced solid tumors. But when it comes to biliary tract cancer (BTC), doctors are still figuring out who gets the most benefit from these treatments. A recent trial focused on pembrolizumab, an IC
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
